Summary

Eligibility
for males ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Anthony Wong
Headshot of Anthony Wong
Anthony Wong

Description

Summary

Official Title

A Phase II Randomized Controlled Trial of Stereotactic Ablative Body Radiotherapy (SAbR) With or Without Neurovascular Sparing for Erectile Function Preservation in Localized Prostate Cancer

Details

Keywords

Prostate Cancer Adenocarcinoma, Erectile dysfunction, Neurovascular, Prostate, Rectal spacer, Radiotherapy, Prostatic Neoplasms, 30Gy (Gray) planning target volume (PTV)

Eligibility

Locations

  • UCSF ( Department of Radiation Oncology UCSF)
    San Francisco California 94143 United States
  • Penrose Hospital
    Colorado Springs Colorado 80907 United States

Lead Scientist at UCSF

  • Anthony Wong
    I am a board-certified radiation oncologist specializing in management of genitourinary malignancies, including prostate, bladder, renal, and testicular malignancies. My clinical areas of expertise include high dose rate (HDR) prostate brachytherapy, stereotactic body radiation therapy (SBRT), and bladder-preserving trimodality therapy.

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of Texas Southwestern Medical Center
ID
NCT03525262
Phase
Phase 2 Prostate Cancer Research Study
Study Type
Interventional
Participants
About 124 people participating
Last Updated